3-hydroxyflavone has been researched along with pd 98059 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YC; Hsu, KC; Ko, CH; Shen, SC | 1 |
| Maher, P | 1 |
| Chen, YC; Lin, CW; Shen, SC; Yang, LY | 1 |
| Kedikaetswe, A; Lim, NR; May, CN; Ng, DC; Thomas, CJ; Woodman, OL; Yeap, YY | 1 |
| Lang, H; Liu, L; Mi, M; Zhou, M; Zhou, Y | 1 |
5 other study(ies) available for 3-hydroxyflavone and pd 98059
| Article | Year |
|---|---|
3-OH flavone inhibition of epidermal growth factor-induced proliferaton through blocking prostaglandin E2 production.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Carcinoma, Squamous Cell; Cell Division; Colony-Forming Units Assay; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Enzyme Activation; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Flavonoids; Gene Expression Regulation, Enzymologic; Humans; Isoenzymes; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 4; Membrane Proteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Prostaglandin-Endoperoxide Synthases; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2004 |
A comparison of the neurotrophic activities of the flavonoid fisetin and some of its derivatives.
Topics: Animals; Cell Differentiation; Extracellular Signal-Regulated MAP Kinases; Flavones; Flavonoids; Flavonols; MAP Kinase Kinase Kinases; Nerve Growth Factors; Neurons; Neuroprotective Agents; PC12 Cells; Rats; Structure-Activity Relationship | 2006 |
IGF-I plus E2 induces proliferation via activation of ROS-dependent ERKs and JNKs in human breast carcinoma cells.
Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Acetylcysteine; Anthracenes; Antineoplastic Agents; Antioxidants; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Estradiol; Extracellular Signal-Regulated MAP Kinases; Female; Flavanones; Flavonoids; Glycosides; Humans; Insulin Receptor Substrate Proteins; Insulin-Like Growth Factor I; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase Kinases; Molecular Structure; Phosphoproteins; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-jun; Quercetin; Reactive Oxygen Species; Signal Transduction; Structure-Activity Relationship; Transfection | 2007 |
Evidence that the MEK/ERK but not the PI3K/Akt pathway is required for protection from myocardial ischemia-reperfusion injury by 3',4'-dihydroxyflavonol.
Topics: Animals; Cardiotonic Agents; Chromones; Drug Therapy, Combination; Female; Flavonoids; Flavonols; MAP Kinase Signaling System; Morpholines; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Phosphatidylinositol 3-Kinases; Primary Cell Culture; Prodrugs; Proto-Oncogene Proteins c-akt; Rats; Sheep; Signal Transduction | 2015 |
Dihydromyricetin enhances glucose uptake by inhibition of MEK/ERK pathway and consequent down-regulation of phosphorylation of PPARĪ³ in 3T3-L1 cells.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Adiponectin; Anilides; Animals; Cell Survival; Dexamethasone; Down-Regulation; Fibroblast Growth Factors; Flavonoids; Flavonols; Glucose; Insulin Resistance; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase Kinases; Phosphorylation; Phosphoserine; PPAR gamma | 2018 |